QSAR: Descriptor calculations, model generation, validation and their application

[1]  P. Nishtala,et al.  An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice , 2016, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[2]  K. Héberger,et al.  Consistency of QSAR models: Correct split of training and test sets, ranking of models and performance parameters† , 2015, SAR and QSAR in environmental research.

[3]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[4]  Alexander D. MacKerell,et al.  Computer-Aided Drug Design Methods. , 2017, Methods in molecular biology.

[5]  David J. Livingstone,et al.  The Use of Artificial Neural Networks in QSAR , 1992 .

[6]  E. Lionta,et al.  Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.

[7]  Yizeng Liang,et al.  Exploring nonlinear relationships in chemical data using kernel-based methods , 2011 .

[8]  Pawan Kumar Gupta,et al.  Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations , 2015, Archives of Toxicology.

[9]  Gabriele Cruciani,et al.  Principal Properties for Aromatic Substituents. A Multivariate Approach for Design in QSAR , 1989 .

[10]  G. Klebe,et al.  Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes , 2018, Nature Communications.

[11]  Gerhard Klebe,et al.  Comparative Molecular Similarity Indices Analysis: CoMSIA , 1998 .

[12]  Tudor I. Oprea,et al.  Target, chemical and bioactivity databases – integration is key , 2006 .

[13]  Hugo Kubinyi,et al.  Free Wilson Analysis. Theory, Applications and its Relationship to Hansch Analysis , 1988 .

[14]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[15]  Alexander Golbraikh,et al.  QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds , 2008, Pharmaceutical Research.

[16]  D. Lesieur,et al.  Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis. , 2001, Journal of medicinal chemistry.

[17]  Sahaya Asirvatham,et al.  Quantitative structure activity relationships studies of non-steroidal anti-inflammatory drugs: A review , 2016, Arabian Journal of Chemistry.

[18]  Alexander Golbraikh,et al.  A Novel Two-Step Hierarchical Quantitative Structure–Activity Relationship Modeling Work Flow for Predicting Acute Toxicity of Chemicals in Rodents , 2009, Environmental health perspectives.

[19]  Alexander Golbraikh,et al.  Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening , 2008, J. Comput. Aided Mol. Des..

[20]  A Tropsha,et al.  QSAR Modeling of Datasets with Enantioselective Compounds using Chirality Sensitive Molecular Descriptors , 2005, SAR and QSAR in environmental research.

[21]  S. Free,et al.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.

[22]  Bernard Testa,et al.  QSAR: Hansch analysis and related approaches , 1995 .

[23]  Bieke Dejaegher,et al.  Feature selection methods in QSAR studies. , 2012, Journal of AOAC International.

[24]  H. Kubinyi.  Comparative Molecular Field Analysis (CoMFA) , 2002 .

[25]  J. Sangshetti,et al.  Recent advances in multidimensional QSAR (4D-6D): a critical review. , 2014, Mini reviews in medicinal chemistry.

[26]  E. Coutinho,et al.  A CoMFA study of COX-2 inhibitors with receptor based alignment. , 2004, Journal of molecular graphics & modelling.

[27]  Hugo Kubinyi,et al.  Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research , 2005, Journal of Cancer Research and Clinical Oncology.

[28]  Samina Kausar,et al.  An automated framework for QSAR model building , 2018, Journal of Cheminformatics.

[29]  A. Bernkop‐Schnürch,et al.  Lipophilic peptide character - What oral barriers fear the most. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Darren V. S. Green,et al.  QSAR workbench: automating QSAR modeling to drive compound design , 2013, Journal of Computer-Aided Molecular Design.

[31]  W. W. Wilkerson.  A quantitative structure—activity relationship analysis of a series of 2′-(2,4-difluorophenoxy)-4′-substituted methanesulfonilides , 1995 .

[32]  Lars Carlsson,et al.  QSAR with experimental and predictive distributions: an information theoretic approach for assessing model quality , 2013, Journal of Computer-Aided Molecular Design.

[33]  Bharat Jhanwarb,et al.  QSAR-Hansch Analysis and Related Approaches in Drug Design , 2011 .

[34]  Yuan-Ling Xia,et al.  Insights into Protein–Ligand Interactions: Mechanisms, Models, and Methods , 2016, International journal of molecular sciences.

[35]  Alexander Tropsha,et al.  Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..

[36]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[37]  Nina Nikolova-Jeliazkova,et al.  QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review , 2005, Alternatives to laboratory animals : ATLA.

[38]  T. Fearn,et al.  Classification and Regression Trees (CART) , 2020, Statistical Learning from a Regression Perspective.

[39]  Bernhard Schölkopf,et al.  A tutorial on support vector regression , 2004, Stat. Comput..

[40]  Artem Cherkasov,et al.  An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin. , 2008, Journal of medicinal chemistry.

[41]  Sudhir A. Kulkarni,et al.  Three-Dimensional QSAR Using the k-Nearest Neighbor Method and Its Interpretation , 2006, J. Chem. Inf. Model..

[42]  A. Debnath,et al.  Quantitative structure-activity relationship (QSAR) paradigm--Hansch era to new millennium. , 2001, Mini reviews in medicinal chemistry.

[43]  Alexander Golbraikh,et al.  Predictive QSAR modeling: Methods and applications in drug discovery and chemical risk assessment , 2012 .

[44]  Rajarshi Guha,et al.  Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..